Business Context and Reporting Period
This Form 6-K filing by NewGenIvf Group Ltd covers the month of November 2025. The report details a corporate action approved by the Board of Directors on November 4, 2025, regarding a reverse stock split intended to maintain compliance with Nasdaq listing requirements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses exclusively on capital structure adjustments rather than operational financial performance.
Material Changes
- Reverse Stock Split: A 1-for-5 reverse stock split was approved for all issued and unissued shares, including Class A and Class B ordinary shares and preferred shares.
- Share Count Reduction: The number of outstanding Class A Ordinary Shares will be reduced from approximately 4,844,490 to approximately 968,898.
- Effective Date: The split is expected to become effective on or around December 3, 2025, with trading on the Nasdaq Capital Market commencing on a post-split basis on that date.
- Adjustments: Outstanding options, warrants, and convertible securities will be adjusted by dividing the exercisable or convertible share count by five.
Guidance, Outlook, and Risks
Management Commentary: The primary objective of the reverse stock split is to ensure the Company remains compliant with the Nasdaq Listing Rule 5550(a)(2), which mandates a minimum bid price of $1.00 per share for continued listing.
Procedural Details: No shareholder vote or approval is required for this action under the BVI Business Companies Act and the Company's Memorandum and Articles of Association (M&A). Fractional shares will not be issued; instead, shareholders entitled to fractional shares will receive one full post-split share.
Risks and Contingencies: The filing does not explicitly list new risks beyond the implication that without this action, the Company may face delisting due to non-compliance with the minimum bid price rule.
Investor Verification Checklist
- Confirm the exact effective date of the reverse stock split (expected December 3, 2025).
- Verify the adjusted share count and price per share on the Nasdaq Capital Market post-implementation.
- Review the specific terms of outstanding options and warrants to confirm the 1-for-5 adjustment calculation.
- Monitor the Company's stock price to ensure it meets the $1.00 minimum bid price requirement following the split.